5 Congress Is Going After the Alleged Price Gougers – Again - Politics Information

Congress Is Going After the Alleged Price Gougers – Again


By Dr. Mark W. Hendrickson


As Yogi Berra, baseball’s preeminent wit and philosopher, would say, “It’s déjà vu all over again.” Fifteen years ago, I wrote in this space about an attempt by Congress to impose additional taxes on oil companies at a time of high gasoline prices.

Last Thursday, the U.S. House of Representatives did it again. It passed “The Consumer Fuel Price Gouging Prevention Act” by a vote of 217-207. Four Democrats and every Republican voted against the bill. The bill would empower the federal government – specifically, the Federal Trade Commission – to fine oil companies if they increase prices in an “excessive” or “exploitative” way (without, in typical congressional vagueness, bothering to define what constitutes “excessive” or “exploitative”).

It is sad that members of Congress who voted for this bill are raging against oil companies when what is really causing the problem is the inexorable economic law of supply and demand. Gasoline prices are uncomfortably high now, not because oil companies are headed by unusually greedy individuals, but because supply is not keeping up with demand.

Consider, if you will, another big market in the U.S. economy – the housing market. The media are full of reports of soaring prices for houses in various parts of the country, often explaining that the price explosion is because supply is not keeping up with demand. What would you think of a federal law imposing a tax on homeowners who take advantage of current market conditions to sell their house for what would have been considered a ridiculously high price just a year ago? You would rebel in righteous indignation, I hope. After all, it is your house, your property, and you should be free to sell it at whatever price you can get in the marketplace. Are homeowners who are receiving top dollar for their houses behaving “exploitatively?” Of course not. That is just the way the real estate market is right now. How is that different from what is happening in the oil market? It isn’t different at all; it’s simply the law of supply and demand at work. The only difference is that some members of Congress believe they can get away with taxing oil companies, whom they routinely demonize, while they know that if they tried to tax homeowners on windfall profits derived from the sale of their homes, they would be voted out of office.

One tactic that the anti-price gouging crowd in Congress is employing against oil companies is to accuse them of deliberately keeping production low and supplies tight. Rep. Katie Porter (D-CA), one of the co-sponsors of the fuel price gouging bill, asserted, “Big Oil is threatening our entire economy by keeping supply low and jacking up prices at the pump.” Similarly, Rep. Frank Pallone (D-NJ), the chair of the House Energy and Commerce Committee, said, “The problem is Big Oil is keeping supply artificially low so prices and profits stay high.”

In the first place, nobody has the right to dictate to a business how much they should produce (well, not in a free-market system based on property rights; under socialism, government does in fact issue such commands). But what makes blaming oil companies for crimped supplies so offensive here is that the Biden administration is in the forefront of efforts to curtail the production of oil.

I wrote twice last year (here and here) about specific anti-oil production policies that the Biden administration has adopted, and those policies haven’t changed a bit. In fact, just a few days before Reps. Porter and Pallone tried to blame oil companies for tight oil supplies, the administration canceled oil leases in the Gulf of Mexico and Cook Inlet. Existing leases are being held in regulatory purgatory by bureaucrats refusing to approve a green light for actual production. A few days ago, Senator Joe Manchin (D-WV) commented that 16 months after the Biden administration announced a pause on granting new oil exploration leases, “we still have no new leases,” and, “it has become crystal clear that the ‘pause’ is in fact a ban.”

With President Biden accompanying his aggressive anti-fossil fuel policies with equally aggressive rhetoric about sharply reducing, if not ending, Americans’ consumption of fossil fuels within the next decade or so, one can understand why oil companies might be hesitant to spend billions to ramp up production. Why should they risk huge losses if that production is going to be shut down not too long from now? Without commenting on if or how fast the U.S. economy should shift from fossil fuels to various “green” modes of energy, the present question is whether the current government policy of impeding the production of oil is hurting us more than it is helping. What do you think?

Dr. Mark W. Hendrickson is a retired adjunct faculty member, economist, and fellow for economic and social policy with the Institute for Faith and Freedom at Grove City College.

More Resources


11/22/2024
Mighty Casey Has Struck Out
Democrat Bob Casey Jr. has served in public office in this state since taking the oath of office as the state auditor general in 1997.

more info


11/22/2024
Gaetz's Implosion Shows Resistance Is Not Futile
Trump's first nominations reveal the serious fractures in his coalition - which can be used to weaken him

more info


11/22/2024
Building a Better Ground Game Critical to Trump's Victory
American Majority Action turned out low-participation voters in battleground States to help Trump and fellow Republicans to victory.

more info


11/22/2024
The Myth That Could Cost Democrats the Next Election
Progressives staying home (almost certainly) didn't cost Kamala Harris the election.

more info


11/22/2024
Jussie Smollett, the Chicago Way and MAGA


more info


11/22/2024
It's Over--Somebody Needs To Tell Bragg's Office


more info


11/22/2024
Congress Must Seize Post-Chevron Opportunity


more info


11/22/2024
Former NIH Director Francis Collins on Trump, RFK Jr.


more info


11/22/2024
How the Left Betrayed the Jews


more info


11/22/2024
I Mean, Seriously Jaguar?
In the aftermath of Trump's victory, the ad already looks like a period piece. But aside from that - I mean, seriously? says Guardian columnist Marina Hyde

more info


11/22/2024
November 22, 1963: JFK and the Futility of Blame


more info


11/22/2024
Dems Have Lost the Plot in the View of Working-Class Voters
The road back to the working class.

more info


11/22/2024
The Trump Counterrevolution Is a Return to Sanity
We are witnessing a historic counterrevolution after Trump's victory, far different from his first election in 2016.

more info


11/22/2024
Harris Disappointed Gen Z
Trump made gains among young voters in 2024, leaving Democrats wondering why.

more info


11/22/2024
Democrats Need Their Own Donald Trump
There may be five stages of grief, but there's usually just one when it comes to political defeat - pretend to soul-search, then carry on as if nothing happened.

more info



Custom Search

More Politics Articles:

Related Articles

5 Financial Pressure Points To Evaluate During COVID Times


Financial pressure is a part of life for most people, and now the COVID-19 pandemic has brought new financial pressure points or exacerbated existing ones for many individuals and families.

Why Are People Complaining About Innovative COVID Treatments?


Gilead Sciences just announced it will charge $3,120 for a full course of Remdesivir, the first new FDA-approved treatment for COVID-19. Some knee-jerk members of Congress like Lloyd Doggett (D-Tex.) immediately condemned that price tag as "outrageous." The Institute for Clinical and Economic Review, a left-leaning nonprofit that releases its own recommendations of "fair" drug prices, claimed that Gilead could afford to price Remdesivir as low as $10 per course of treatment -- the cost of the raw ingredients used to make the drug.

Proposed Healthcare Reforms Will Not Help the Latinx Community


Joe Biden is officially the Democratic presidential nominee, all thanks to his moderate reputation.

Trade Enforcement Can Accelerate America's Economic Recovery


The stock market has largely rebounded from COVID-19 and American retail sales are improving steadily. Even more encouraging is that the U.S. unemployment rate fell for the fifth consecutive month in September. Each of these gains are sure signs that the Trump administration's economic response to the coronavirus crisis is working.

Drug Price Controls: Right Objective, Wrong Solution


This month, President Trump signed an executive order to reduce Medicare spending on prescription drugs. For each medication, Medicare will pay no more than the lowest price available in other developed countries.

Keep Thanksgiving, Family and Friends Alive


Joe Biden or Donald Trump will never visit me in my home, stand beside me at the funeral home or dance at my wedding. I will not be receiving any calls from either of them to pray for me during sickness or to check on how my children are doing. I probably will never sit in a room with them to visit, laugh and tell funny stories or just to hang out over a cup of coffee. I do not personally know either one. I welcome the opportunity to visit with either of them, but doubt it will happen.

The "E" Stands for “Excellence:” Remembering Walter E. Williams


Walter E. Williams, prolific author, piercing cultural commentator, old school economist (that’s a good thing), devoted husband, loving father, and long-time friend of Grove City College has passed from this world.

How Congress Can Really Fix Surprise Billing


House and Senate leaders recently agreed on legislation to end surprise medical bills as part of a big coronavirus relief package. President Trump signed it into law at the end of December.

A Federal Rule Will Reverse Strides in Cancer Treatment


"You've got cancer." That's one of the scariest sentences in the English language.

Biden Must Restore Seniors' Access to Essential Medicines


On January 19, Medicare officials announced a new payment model that could wreak havoc on the chronically ill.

Violence In America, Don't Be Surprised


The most recent attack at the United States Capitol will most likely insure a permanent fence and additional security. The attack which resulted in the loss of life for a long serving Capitol police officer and the attacker is another senseless violent act.

Protecting the Innovation that Protects Global Health


The most far-reaching healthcare policy decision of 2021 won't be made in Congress or the White House. It will be made at the World Trade Organization, which is considering a petition to waive all patent rights on Covid-19 vaccines.

Don't Repeat Europe's Vaccine Catastrophe


For many Americans, the calamitously slow vaccine roll-out in countries like Germany, France, and Italy comes as a surprise. After all, in the early days of the pandemic, Europe's response to the crisis seemed highly competent, especially compared to the United States.

A Full Plate for the New U.S. Trade Czar


The newly confirmed U.S. trade representative, Katherine Tai, is about as qualified as a person can be for the job. Which is a good thing, because she already faces a series of challenges.

Don't Let the US Import Europe's Failed Cancer Policies


With a majority in both the House and Senate and control of the Oval Office, Democratic leaders are excited about the prospect of making significant changes. One good example of this is the House Democrats' "Lower Drug Costs Now Act."